Gut microbiota and mucosal surface

The gut microbiota and mucosal surface represent a complex, symbiotic interface between the host and trillions of microorganisms. The mucosal surface, primarily composed of epithelial cells and a protective mucus layer, serves as a physical and immunological barrier that prevents the translocation of pathogens while allowing nutrient absorption (Source: NIH, PubMed). The gut microbiota plays a critical role in training the host immune system, synthesizing essential vitamins, and fermenting dietary fibers into short-chain fatty acids like butyrate, which provide energy to colonocytes (Source: Nature Reviews Microbiology). Dysregulation of this interface, often termed dysbiosis or barrier dysfunction, is implicated in a wide range of conditions, including inflammatory bowel disease, metabolic disorders, and even neurodegenerative diseases via the gut-brain axis (Source: Science). Therapeutic strategies targeting this system include probiotics, prebiotics, and fecal microbiota transplantation, which aim to restore microbial balance and reinforce barrier integrity (Source: Gastroenterology). Because this is a multi-component system rather than a single receptor, drug development often focuses on specific microbial metabolites or signaling pathways like the aryl hydrocarbon receptor or G protein-coupled receptors (Source: Cell).

Other names

Intestinal microbiomeGut-mucosal barrierCommensal floraIntestinal mucosaGastrointestinal microbiota

Modulation of microbial diversity, restoration of epithelial barrier integrity, competitive inhibition of pathogens, and production of bioactive metabolites like short-chain fatty acids.